Page last updated: 2024-08-25

irinotecan hydrochloride and Experimental Neoplasms

irinotecan hydrochloride has been researched along with Experimental Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Attiogbe, MKI; Cao, L; Cao, YX; Du, SS; Fan, S; Hei, YY; Lei, H; Li, GY; Liu, YJ; Yang, XY; Yao, JC; Zhang, GM; Zhang, H; Zhang, SQ; Zhang, XY	1

Other Studies

1 other study(ies) available for irinotecan hydrochloride and Experimental Neoplasms

Article	Year
F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent. European journal of medicinal chemistry, 2020, Sep-15, Volume: 202 Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Biological Availability; Camptothecin; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Tumor Cells, Cultured	2020

Article

Year

F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.

European journal of medicinal chemistry, 2020, Sep-15, Volume: 202

Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Biological Availability; Camptothecin; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Tumor Cells, Cultured

2020